3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
3
Other
1
Conditions
Sexuality
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Breast Neoplasms
1
Interventions
Exercise
9
exemestane
4
Psychiatric Rehabilitation
4
Tamoxifen
3
Methods
3
Metformin
3
Letrozole
3
Early Intervention, Educational
3
Diet Therapy
3
Bupropion
3
Bariatric Surgery
3
Anastrozole
3
Vitamin D
2
Therapeutics
2
Sugars
2
Specimen Handling
2
Naltrexone
2
Mammography
2
Diet, Mediterranean
2
Counseling
2
Cognitive Behavioral Therapy
2
Cholecalciferol
2
Blood Specimen Collection
2
rosiglitazone-metformin combination
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Yoga
1
Walking
1
Tirzepatide
1
Testosterone Propionate
1
Testosterone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Testosterone Propionate
×
Other
×
Clear all
NCT00612742
2021-10-29
BLOOM
BioSante Pharmaceuticals
Phase 3
Completed
3,656 enrolled